CAPRICOR THERAPEUTICS, INC. Deferred Revenue (Non-Current)
CAPRICOR THERAPEUTICS, INC. (CAPR) had Deferred Revenue (Non-Current) of $0 as of 2016-12-31, per its 10-K filed 2017-03-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent › Deferred Revenue, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2017-03-16
- 2016-12-31: Deferred Revenue, Noncurrent $0.00.
- 2016-09-30: Deferred Revenue, Noncurrent $0.00.
- 2016-06-30: Deferred Revenue, Noncurrent $0.00.
- 2016-03-31: Deferred Revenue, Noncurrent $0.00.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-16 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-14 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-15 |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-13 |
| 2015-12-31 | $911.46K 10-K · filed 2017-03-16 |
| 2015-09-30 | $1.82M 10-Q · filed 2015-11-13 |
| 2015-06-30 | $2.73M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $3.12M 10-Q · filed 2015-05-13 |
| 2014-12-31 | $4.17M 10-K · filed 2016-03-30 |
| 2014-09-30 | $5.21M 10-Q · filed 2014-11-14 |
| 2014-06-30 | $6.25M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $7.29M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |